FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964498839> ?p ?o ?g. }

• W1964498839 abstract "Selective inhibitors of cyclooxygenase-2 (prostaglandin-endoperoxide synthase-2; COX-2) augment the rate of hexose uptake in myotubes by recruiting glucose transporter-4 (GLUT-4) to the plasma membrane in an insulin- and AMPKalpha-independent manner [Alpert E, Gruzman A, Lardi-Studler B, Cohen G, Reich R, Sasson S. Cyclooxygenase-2 (PTGS2) inhibitors augment the rate of hexose transport in L6 myotubes in an insulin- and AMPKalpha-independent manner. Diabetologia 2006;49:562-70]. We aimed at elucidating the molecular interactions that mediate this effect of COX-2 inhibitors in L6 myotubes. The effects of the inhibitors niflumic acid, nimesulide and rofecoxib on activities and phosphorylation state of key proteins in the insulin transduction pathway were determined. These inhibitors did not induce specific tyrosine phosphorylation in IRS-1, could not assemble a functional IRS-PI3K-PKB/Akt complex and did not activate GSK3alpha/beta, JNK1/2, ERK1/2, p38-MAPK or c-Cbl by site-specific phosphorylation(s). Yet, like insulin, they activated mTOR and induced downstream threonine phosphorylation in p70S6K and 4EBP1. However, rapamycin, which inhibits mTOR enzymatic activity, did not interfere with COX-2 inhibitor-induced stimulation of hexose uptake in myotube. Thus, mTOR activation was not required for COX-2 inhibitor-dependent augmentation of hexose transport in myotubes. Because PKCdelta has also been shown to activate mTOR, we asked whether COX-2 inhibitors activate mTOR by a prior activation of PKCdelta. Indeed, all three inhibitors induced tyrosine phosphorylation in PKCdelta and stimulated its kinase activity. Moreover, pharmacological inhibition of PKCdelta or the expression of a dominant-negative form of PKCdelta in myotubes completely abolished COX-2 inhibitor-dependent stimulation of hexose uptake. This study shows that selective COX-2 inhibitors activate a unique PKCdelta-dependent pathway to increase GLUT-4 abundance in the plasma membrane of myotubes and augment the rate of hexose transport." @default.
• W1964498839 created "2016-06-24" @default.
• W1964498839 creator A5028232112 @default.
• W1964498839 creator A5050472899 @default.
• W1964498839 creator A5050527834 @default.
• W1964498839 creator A5088201458 @default.
• W1964498839 date "2007-02-01" @default.
• W1964498839 modified "2023-10-16" @default.
• W1964498839 title "Selective cyclooxygenase-2 inhibitors stimulate glucose transport in L6 myotubes in a protein kinase Cδ-dependent manner" @default.
• W1964498839 cites W1538433900 @default.
• W1964498839 cites W1583477127 @default.
• W1964498839 cites W1591129275 @default.
• W1964498839 cites W1596496113 @default.
• W1964498839 cites W1876309946 @default.
• W1964498839 cites W1964826115 @default.
• W1964498839 cites W1970002782 @default.
• W1964498839 cites W1972202513 @default.
• W1964498839 cites W1973523864 @default.
• W1964498839 cites W1974499645 @default.
• W1964498839 cites W1976275824 @default.
• W1964498839 cites W1979801144 @default.
• W1964498839 cites W1980799974 @default.
• W1964498839 cites W1981460885 @default.
• W1964498839 cites W1985325808 @default.
• W1964498839 cites W1987343071 @default.
• W1964498839 cites W1992976490 @default.
• W1964498839 cites W2003885135 @default.
• W1964498839 cites W2004767178 @default.
• W1964498839 cites W2012801178 @default.
• W1964498839 cites W2012870455 @default.
• W1964498839 cites W2022008301 @default.
• W1964498839 cites W2024512779 @default.
• W1964498839 cites W2029208833 @default.
• W1964498839 cites W2031376937 @default.
• W1964498839 cites W2035230751 @default.
• W1964498839 cites W2035672058 @default.
• W1964498839 cites W2035836674 @default.
• W1964498839 cites W2037230449 @default.
• W1964498839 cites W2039455217 @default.
• W1964498839 cites W2048077439 @default.
• W1964498839 cites W2063351843 @default.
• W1964498839 cites W2070255471 @default.
• W1964498839 cites W2092887892 @default.
• W1964498839 cites W2093881154 @default.
• W1964498839 cites W2101711148 @default.
• W1964498839 cites W2102043357 @default.
• W1964498839 cites W2105552847 @default.
• W1964498839 cites W2120753520 @default.
• W1964498839 cites W2121216806 @default.
• W1964498839 cites W2126681184 @default.
• W1964498839 cites W2130270853 @default.
• W1964498839 cites W2135499185 @default.
• W1964498839 cites W2141277427 @default.
• W1964498839 cites W2146187080 @default.
• W1964498839 cites W2159628790 @default.
• W1964498839 cites W2170371239 @default.
• W1964498839 cites W4256264762 @default.
• W1964498839 doi "https://doi.org/10.1016/j.bcp.2006.10.008" @default.
• W1964498839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17098211" @default.
• W1964498839 hasPublicationYear "2007" @default.
• W1964498839 type Work @default.
• W1964498839 sameAs 1964498839 @default.
• W1964498839 citedByCount "11" @default.
• W1964498839 countsByYear W19644988392013 @default.
• W1964498839 countsByYear W19644988392014 @default.
• W1964498839 countsByYear W19644988392015 @default.
• W1964498839 crossrefType "journal-article" @default.
• W1964498839 hasAuthorship W1964498839A5028232112 @default.
• W1964498839 hasAuthorship W1964498839A5050472899 @default.
• W1964498839 hasAuthorship W1964498839A5050527834 @default.
• W1964498839 hasAuthorship W1964498839A5088201458 @default.
• W1964498839 hasConcept C11960822 @default.
• W1964498839 hasConcept C134018914 @default.
• W1964498839 hasConcept C161573976 @default.
• W1964498839 hasConcept C185592680 @default.
• W1964498839 hasConcept C195794163 @default.
• W1964498839 hasConcept C2776188179 @default.
• W1964498839 hasConcept C2777553839 @default.
• W1964498839 hasConcept C2779306644 @default.
• W1964498839 hasConcept C2780124434 @default.
• W1964498839 hasConcept C55493867 @default.
• W1964498839 hasConcept C62478195 @default.
• W1964498839 hasConcept C75217442 @default.
• W1964498839 hasConcept C86554907 @default.
• W1964498839 hasConcept C86803240 @default.
• W1964498839 hasConcept C97029542 @default.
• W1964498839 hasConceptScore W1964498839C11960822 @default.
• W1964498839 hasConceptScore W1964498839C134018914 @default.
• W1964498839 hasConceptScore W1964498839C161573976 @default.
• W1964498839 hasConceptScore W1964498839C185592680 @default.
• W1964498839 hasConceptScore W1964498839C195794163 @default.
• W1964498839 hasConceptScore W1964498839C2776188179 @default.
• W1964498839 hasConceptScore W1964498839C2777553839 @default.
• W1964498839 hasConceptScore W1964498839C2779306644 @default.
• W1964498839 hasConceptScore W1964498839C2780124434 @default.
• W1964498839 hasConceptScore W1964498839C55493867 @default.
• W1964498839 hasConceptScore W1964498839C62478195 @default.
• W1964498839 hasConceptScore W1964498839C75217442 @default.
• W1964498839 hasConceptScore W1964498839C86554907 @default.
• W1964498839 hasConceptScore W1964498839C86803240 @default.

• next